The 5 Ts of Bifurcation Intervention: Type, Technique, Two Stents, T-Stenting, Trials**Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.

JACC: Cardiovascular Interventions

Volumn 1, Issue 4, 2008, Pages 366-368

  Waksman, Ron ^a   Bonello, Laurent ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

angioplasty; bifurcation lesions; drug eluting stents; stent thrombosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANATOMICAL VARIATION; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EDITORIAL; HEART INFARCTION; HUMAN; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; SURGICAL ANATOMY; SURGICAL TECHNIQUE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS AS TOPIC; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; RESEARCH DESIGN; RISK ASSESSMENT; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49449091486     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.06.006     Document Type: Editorial

References (20)

1. Routledge H.C., Morice M.-C., Lefèvre T., et al. 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents. J Am Coll Cardiol Intv 1 (2008) 358-365
2. Medina A., Suárez de Lezo J., and Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59 (2006) 183
3. Thomas M., Hildick-Smith D., Louvard Y., et al. Percutaneous coronary intervention for bifurcation disease. A consensus view from the first meeting of the European bifurcation club. Euro Intervention 2 (2006) 149-153
4. Louvard I., Lefevre T., and Morice M.C. Percutaneous coronary intervention for bifurcation coronary disease. Heart 90 (2004) 713-722
5. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
6. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
7. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
8. Carrie D., Karouny E., Chouairi S., and Puel J. "T" shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cathet Cardiovasc Diagn 37 (1996) 311-313
9. Steigen T.K., Maeng M., Wiseth R., et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic Bifurcation study. Circulation 114 (2006) 1955-1961
10. Gunnes P, Niemela M, Kervinen K, et al, for the Nordic-Baltic PCI Study Group. Eight months angiographic follow-up in patients randomized to crush or culotte stenting of coronary artery bifurcation lesions. The Nordic Bifurcation Stent Technique study. Paper presented at: ACC 2008 Late Breaking Trials; April 1, 2008; Chicago, IL.
11. Palvakis G., de Man F., Hamer B., Doevendas P., and Stella P.R. Registry of new technique on coronary bifurcation lesions: the Utrech-"T" experience. Euro Intervention 3 (2007) 262-268
12. Pan M., Suárez de Lezo J., Medina A., et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153 (2007) 15-17
13. Ormiston J.A., Webster M.W., El Jack S., et al. Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv 67 (2006) 49-55
14. Ge L., Airoldi F., Iakovou I., et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 46 (2005) 613-620
15. Hoye A., Iakovou I., Ge L., et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 47 (2006) 1949-1958
16. Sharma S.K. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv 65 (2005) 10-16
17. Moussa I., Costa R.A., Leon M.B., et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". Am J Cardiol 97 (2006) 1317-1321
18. Yanagi D., Shirai K., Takamiya Y., et al. Results of provisional stenting with a sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan. J Cardiol 51 (2008) 89-94
19. Di Mario C., Morici N., Godino C., et al. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv 69 (2007) 416-424
20. Tsuchida K., Colombo A., Lefèvre T., et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 28 (2007) 433-442